The Role of Fibroblast Growth Factor 19 in Hepatocellular Carcinoma
- 14 May 2021
- journal article
- review article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 191 (7), 1180-1192
- https://doi.org/10.1016/j.ajpath.2021.04.014
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R00LM011673, P30CA047904)
- National Cancer Institute (R00LM011673, P30CA047904)
This publication has 100 references indexed in Scilit:
- Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-KlothoProceedings of the National Academy of Sciences of the United States of America, 2012
- FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α PathwayCell Metabolism, 2011
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic ScreeningCancer Cell, 2011
- The role of microRNAs in liver cancer progressionBritish Journal of Cancer, 2010
- Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)Proceedings of the National Academy of Sciences of the United States of America, 2010
- The FGF family: biology, pathophysiology and therapyNature Reviews Drug Discovery, 2009
- Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expressionJournal of Hepatology, 2008
- Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesisMolecular Carcinogenesis, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008